Concord Biotech's Unit I receives Brazilian Health Regulatory Agency approval

Concord Biotech announced that Brazilian Health Regulatory Agency (ANVISA) has conducted inspection of the company's Unit I (API facility) of the Company, located at Trasad Road, Dholka - 382225 in Ahmedabad, Gujarat from 29 January 2024 to 01 February 2024.

The said inspection has been completed successfully, without any adverse remarks.

Powered by Capital Market - Live News